Protara Therapeutics (TARA)
Develops investigational therapies for cancer, lymphatic malformations, and patients receiving parenteral support.
$3.55
vs last close−0.14 (−3.67%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
estimated · in 47 days
EPS estimate
−$0.37
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.48−$0.29−$0.35−$0.31−$0.37−$0.31−$0.36Pending
Estimate−$0.57−$0.47−$0.43−$0.39−$0.32−$0.36−$0.33−$0.37
Surprise+15.8%+38.3%+18.6%+20.5%−15.6%+13.9%−10.5%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported——————$180.0KPending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.50 | — | — |
| Sep 2027 | −$0.49 | — | — |
| Jun 2027 | −$0.50 | — | — |
| Mar 2027 | −$0.46 | — | — |
| Dec 2026 | −$0.37 | — | — |
| Nov 2026 | −$0.37 | — | — |
| Aug 2026 | −$0.33 | −$0.36 | −10.5% |
| May 2026 | −$0.36 | −$0.31 | +13.9% |
| Mar 2026 | −$0.32 | −$0.37 | −15.6% |
| Nov 2025 | −$0.39 | −$0.31 | +20.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Oct 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.50 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.49 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.50 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.46 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.37 | — | — | $0 | — | — | — |
| Nov 9, 2026 | −$0.37 | — | — | $0 | — | — | — |
| Aug 11, 2026 | −$0.33 | −$0.36 | −10.5% | — | $180.0K | — | −4.9% |
| May 13, 2026 | −$0.36 | −$0.31 | +13.9% | — | — | — | +1.0% |
| Mar 10, 2026 | −$0.32 | −$0.37 | −15.6% | — | — | — | −0.7% |
| Nov 10, 2025 | −$0.39 | −$0.31 | +20.5% | — | — | — | +5.6% |
| Aug 11, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 5, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 2, 2024 | |||||||
| Mar 13, 2024 | |||||||
| Nov 3, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 8, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 9, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 11, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Jul 31, 2020 | |||||||
| May 13, 2020 | |||||||
| Mar 20, 2020 | |||||||
| Oct 31, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 8, 2019 | |||||||
| Mar 13, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 9, 2018 | |||||||
| Mar 14, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 7, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 16, 2017 | |||||||
| Nov 7, 2016 | |||||||
| Aug 8, 2016 | |||||||
| May 9, 2016 | |||||||
| Mar 14, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 13, 2015 |